Literature DB >> 8521364

Toxic effects and drug interactions of antimycobacterial therapy.

N H Chan-Tompkins1.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 8521364     DOI： 10.1016/0738-081x(95)00022-8

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN： 0738-081X            Impact factor:   3.541


× No keyword cloud information.
  4 in total

1.  Screening of antifungal azole drugs and agrochemicals with an adapted alamarBlue-based assay demonstrates antibacterial activity of croconazole against Mycobacterium ulcerans.

Authors:  Nicole Scherr; Katharina Röltgen; Matthias Witschel; Gerd Pluschke
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

2.  Comparative Study of Activities of a Diverse Set of Antimycobacterial Agents against Mycobacterium tuberculosis and Mycobacterium ulcerans.

Authors:  Nicole Scherr; Gerd Pluschke; Manoranjan Panda
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

3.  Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study.

Authors:  Daniel P O'Brien; Anthony McDonald; Peter Callan; Mike Robson; N Deborah Friedman; Andrew Hughes; Ian Holten; Aaron Walton; Eugene Athan
Journal:  PLoS Negl Trop Dis       Date:  2012-01-17

4.  Bactericidal activity does not predict sterilizing activity: the case of rifapentine in the murine model of Mycobacterium ulcerans disease.

Authors:  Deepak V Almeida; Paul J Converse; Si-Yang Li; Sandeep Tyagi; Eric L Nuermberger; Jacques H Grosset
Journal:  PLoS Negl Trop Dis       Date:  2013-02-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.